Omega-3, underrated: what the research actually shows about period pain and inflammation

If you take ibuprofen on day 1 and 2 of your period like clockwork, you are not alone. Roughly half of menstruating women experience pain severe enough to interfere with daily activity, and the standard recommendation is the same it was thirty years ago: a non-steroidal anti-inflammatory drug like ibuprofen. It works. It also has a cost, especially when you are taking it every month for decades.

There is a quieter line of evidence that has been building for the last decade. A meta-analysis of 41 randomized controlled trials covering nearly 3,800 women found that omega-3 supplementation produced a moderate, statistically and clinically significant reduction in menstrual pain intensity, with the effect strengthening over time ^[1]. The same research base is also showing meaningful improvements in PMS symptoms, mood, and inflammatory markers. Omega-3 is one of the most consistently under-consumed nutrients in the European diet, and one of the most consistently underestimated in women's health.

This article walks through what omega-3 is, what the research actually shows about period pain and PMS, what the EU regulator has authorised as a health claim, and what nōuxx does and does not currently provide. Omega-3 is not in the nōuxx cycle routine, and this article is not a pitch. It is an honest read of an evidence base women should know about.

What omega-3 actually is

Omega-3 is a family of polyunsaturated fatty acids. The three relevant ones for human health are:

• ALA (alpha-linolenic acid): the plant form, found in flax, chia, walnuts, and rapeseed oil
• EPA (eicosapentaenoic acid): the marine form, found in oily fish and microalgae
• DHA (docosahexaenoic acid): also marine, found in the same sources

Your body can convert ALA to EPA and DHA, but the conversion rate is small. The research consistently shows ALA-to-EPA conversion is around 5 to 10%, and ALA-to-DHA conversion is closer to 0.5 to 5% in women, with the rate dependent on sex hormones, diet, and individual genetics ^[2]. In practical terms: if you do not eat oily fish or use a direct EPA/DHA supplement, your tissue levels of EPA and DHA will tend to be low regardless of how much flax you eat.

This matters because most of the clinical evidence for omega-3 in women's health is built on EPA and DHA, not ALA.

What the EU regulator says

The European Food Safety Authority has reviewed the evidence on EPA and DHA and authorised the following health claims under EU law ^[3]:

• EPA and DHA contribute to the normal function of the heart (at 250 mg/day combined intake)
• DHA contributes to the maintenance of normal brain function (at 250 mg/day)
• DHA contributes to the maintenance of normal vision (at 250 mg/day)
• EPA and DHA contribute to the maintenance of normal blood pressure (at 3 g/day)
• EPA and DHA contribute to the maintenance of normal blood triglyceride levels (at 2 g/day)
• DHA maternal intake contributes to the normal brain and eye development of the foetus and breastfed infants (during pregnancy and breastfeeding)

That is one of the strongest sets of authorised claims for any single nutrient class. What is not on that list, and this is the regulatory point, is "reduces period pain." Period pain reduction is reported in randomized trials, summarised in meta-analyses, and described in this article as a research finding. It is not a nōuxx claim, and no supplement brand is permitted to make it under EU food law.

The European intake gap

Most European women are not hitting the EFSA's 250 mg/day combined EPA + DHA target. A 2025 analysis of European consumption data found that average daily EPA/DHA intake is roughly 50 times lower than vegetable oil intake ^[4]. Studies in specific populations are even more pointed: one pilot study in elite female athletes in Europe found only 23% met the 250 mg/day EFSA guideline ^[5].

The gap is structural. Oily fish (salmon, mackerel, sardines, herring, anchovies) is the dominant dietary source, and many women either dislike fish, avoid it for sustainability reasons, or eat it less than once per week. Plant-based women are particularly affected, since ALA conversion to EPA and DHA is slow and incomplete.

How omega-3 affects inflammation (and why that matters for your cycle)

Menstrual pain is, mechanistically, an inflammation story. The lining of your uterus produces prostaglandins, signalling molecules that drive the contractions which shed the lining. The pain you feel during a period is largely driven by prostaglandin F2-alpha, with input from leukotrienes and other inflammatory mediators.

Omega-3 fatty acids change this biochemistry at the source. EPA and DHA compete with arachidonic acid (the omega-6 precursor of inflammatory prostaglandins) for the same enzymatic pathways. When your tissue ratio of omega-3 to omega-6 shifts, your body produces less of the strongly inflammatory series-2 prostaglandins and more of the milder series-3 prostaglandins ^[6][7].

There is also a second mechanism. EPA and DHA give rise to a class of signalling molecules called resolvins, protectins, and maresins, collectively known as specialised pro-resolving mediators. These do not just dampen inflammation, they actively switch it off and accelerate tissue recovery ^[6]. This is a fundamentally different mechanism from ibuprofen, which blocks the enzyme COX without addressing the underlying inflammatory tone.

The clinical implication: if you increase your omega-3 status over weeks to months, you are shifting the inflammatory baseline of every tissue in your body, including your uterus. That is why the effects in trials are modest at one month and substantial at six months.

What the research actually shows about period pain

The headline meta-analysis on this topic was published in Pain in 2024. It pooled data from 41 randomized controlled trials covering 3,759 women with primary dysmenorrhea ^[1]. The findings:

• Omega-3 produced a moderate, statistically and clinically significant reduction in pain intensity (standardised mean difference -0.55, 95% CI -0.76 to -0.34)
• The effect appeared at 1 month (SMD -0.27) and strengthened by 6 months (SMD -0.83)
• Doses at or below 1.35 g/day were at least as effective as higher doses (SMD -0.60 vs -0.53)
• A separate 2024 systematic review in Nutrition and Dietetics found a large effect size (d = -1.02) ^[8]

The takeaway is not that omega-3 is a replacement for ibuprofen. The takeaway is that consistent omega-3 intake over months can meaningfully reduce baseline period pain, which means less reliance on NSAIDs and potentially less of the GI burden that comes with monthly ibuprofen use across decades.

What the research shows about PMS

The evidence for PMS is also building, though it is smaller. A 2022 systematic review and meta-analysis in the Journal of Obstetrics and Gynaecology Research synthesised the available trials and found that omega-3 supplementation reduced the severity of PMS in women across multiple symptom dimensions ^[9]. Specific trials worth knowing:

• A 2017 randomized, placebo-controlled trial in 95 Iranian women aged 20–35 found that 1 g/day of fish oil reduced PMS symptoms and improved health-related quality of life over the supplementation period ^[10]
• A 2012 randomized double-blind trial in 184 women with PMS found that after 45 days of omega-3 treatment, depression, anxiety, and lack of concentration scores improved significantly compared to placebo ^[11]
• Rocha Filho et al. randomised 120 Brazilian women to placebo, 1 g/day, or 2 g/day omega-3 for 6 months. The 2 g/day arm showed significant improvement in total PMS scores at 3 and 6 months The PMS findings parallel the dysmenorrhea findings: dose around 1 to 2 g/day, effect takes weeks to months to manifest, both physical and psychological symptoms respond.

Sources and forms: fish oil, algae oil, ratios, quality

If you are going to add omega-3 to your nutrition routine, the choices matter.

Source: - Oily fish (salmon, mackerel, sardines, herring, anchovies): 1 to 2 servings per week of cold-water oily fish typically delivers ~250–500 mg EPA + DHA per day averaged across the week - Fish oil supplements: higher EPA content, lower cost, well-studied - Algae oil supplements: the only direct plant-based source of preformed EPA and DHA. Bioavailability of DHA from microalgae is statistically non-inferior to fish oil in clinical studies, though algae oil is typically higher in DHA and lower in EPA than fish oil ^[12]

For period pain and PMS specifically, the trials almost universally used fish oil with EPA-leaning ratios. If you choose algae, look for a product with both EPA and DHA, not DHA alone.

Form: - Triglyceride (TG) and re-esterified triglyceride (rTG) forms are absorbed more efficiently than the cheaper ethyl ester (EE) form - Phospholipid-bound omega-3 (such as krill oil) shows comparable bioavailability to triglyceride fish oil, though at higher cost

Quality markers to look for: - Third-party tested for heavy metals, PCBs, and oxidation (look for IFOS certification or equivalent) - A low TOTOX (total oxidation) value - Cold-stored, with antioxidants (typically natural tocopherols) - Stated EPA and DHA per capsule, not just "omega-3 1000 mg"

Dose: EFSA's authorised heart claim is satisfied at 250 mg/day combined EPA + DHA. The dysmenorrhea trial evidence suggests 1.0 to 1.35 g/day produces the strongest effect. EFSA's safety review concluded that combined EPA + DHA up to 5 g/day raises no safety concern in healthy adults ^[13]. Most women will be well-served by 500 mg to 1 g/day.

What blocks the benefit (or speeds it up)

Omega-3 is a slow-acting intervention. You are changing the fatty acid composition of every cell membrane in your body, which takes time. A few practical points:

• It takes 8 to 12 weeks for omega-3 supplementation to meaningfully shift tissue levels and start delivering the effects measured in trials
• High omega-6 intake (most seed oils, fried food, ultra-processed food) competes for the same enzymatic pathways and dampens the effect. Reducing the omega-6 to omega-3 ratio matters as much as the absolute omega-3 dose
• Oxidised oil (rancid fish oil) may actually increase oxidative stress. Storage and quality matter
• Take with a meal containing fat for better absorption, particularly for the ethyl ester form

How this fits with the nōuxx routine

To be direct: omega-3 is not currently in the nōuxx cycle routine. There are two honest reasons.

The formulation reason. Omega-3 fatty acids (EPA and DHA) are chemically among the most oxidation-prone nutrients in the human diet. The same polyunsaturated double bonds that make them anti-inflammatory in your tissues also make them highly reactive with oxygen, light, and heat outside the body. The result is that omega-3 in dry powder form has a meaningfully harder shelf-life and stability story than nutrients like magnesium bisglycinate, iron bisglycinate, or B vitamins.

The standard manufacturing route to put omega-3 into a powder is microencapsulation, typically by spray-drying fish or algae oil with a wall material like sodium caseinate, maltodextrin, modified starch, or gum arabic ^[14]. The fish oil ends up embedded as microscopic droplets inside a polymer matrix that is supposed to protect it from oxygen.

The trade-offs are well-documented in the food-science literature:

• The drying process itself exposes the oil to a lot of oxygen, accelerating the oxidation it is meant to prevent ^[15]
• Smaller particles have more surface area exposed to surrounding air, leading to faster oxidation ^[14]
• Effective payload is low. A microencapsulated powder typically contains only 20 to 60% omega-3 by weight; the rest is wall material. To deliver the 500 to 1000 mg EPA + DHA dose that has clinical evidence, you would need 1 to 5 grams of powder per serving, often more
• Shelf life is meaningfully shorter than capsules. Some studies report oxidative stability windows as short as 5 weeks at room temperature for spray-granulated fish oil powders without aggressive antioxidant systems ^[16]
• Independent product testing has consistently flagged oxidation even in well-formulated commercial omega-3 supplements, with one analysis finding 68% of flavoured and 13% of unflavoured products exceeded acceptable oxidation levels ^[17]

nōuxx is a powder system. The format works extremely well for water-soluble vitamins, minerals like iron bisglycinate and magnesium bisglycinate, amino acids like L-tryptophan and glycine, and similar compounds where dry stability is straightforward. It does not currently work as cleanly for omega-3 at the doses backed by the trial evidence.

The fit reason. Even if formulation were easy, omega-3 is an evergreen, cumulative-build nutrient, not a phase-specific one. The clinical effects on dysmenorrhea and PMS appear over 1 to 6 months of consistent intake and reflect a sustained shift in tissue fatty-acid composition. There is no clear "menstrual phase" or "luteal phase" benefit to dosing differently across the cycle. That logic fits a daily oil capsule or a fortified meal pattern, not a phase-rotating powder routine.

The honest practical recommendation is: take the nōuxx routine for the phase-specific micronutrient story it is built around (iron in the menstrual phase, magnesium in the luteal phase, fertility-supporting nutrients in the follicular and ovulatory windows), and add a separate omega-3 source (oily fish 1 to 2 times per week, a triglyceride-form fish oil capsule, or algae oil for plant-based women) for the months-long anti-inflammatory baseline shift. The two layers do different jobs and do not need to live in the same product.

Common questions

How long until I feel something?

For period pain specifically, the trial evidence shows noticeable improvement at 1 month and stronger effects at 3 to 6 months. For PMS symptoms, similar timeline. This is a slow-acting intervention, not a same-cycle fix.

Can I get enough from food alone?

Yes, but the threshold is specific. 1 to 2 servings of cold-water oily fish per week (around 140 g per serving of salmon, mackerel, sardines, or herring) brings most women within EFSA's 250 mg/day target on average. Plant sources (flax, chia, walnuts, rapeseed oil) provide ALA but conversion to EPA and DHA is slow and incomplete. If you do not eat fish, a supplement is the practical route.

Is algae oil really equivalent to fish oil?

Bioavailability of DHA from microalgal sources is statistically non-inferior to fish oil in controlled trials ^[12]. The caveat is that algae oil is typically high in DHA and lower in EPA than fish oil, and the dysmenorrhea evidence base uses mostly EPA-containing fish oil. For period pain and PMS specifically, an algae product with both EPA and DHA is preferable to DHA-only.

Can I just eat flax instead?

Flax provides ALA, which your body converts to EPA at about 5 to 10% efficiency and to DHA at under 5% efficiency ^[2]. For general cardiovascular and brain health, ALA from flax has its own evidence base. For the period pain and PMS evidence specifically, the trials use EPA and DHA directly, not ALA precursor. Flax is a good food; it is not a clinical substitute for marine omega-3.

What about fish oil burps?

The classic complaint. Enteric-coated capsules and triglyceride-form products both substantially reduce reflux and "fishy burps." Storing capsules in the fridge also helps. If burps are persistent, the oil may be oxidised; switch products.

Is it safe in pregnancy?

Yes, and EFSA has authorised a specific claim for it: "DHA maternal intake contributes to the normal brain and eye development of the foetus and breastfed infants" at an additional 200 mg DHA per day on top of the adult baseline ^[3]. If pregnant or planning pregnancy, talk to your midwife or GP about the right product (pregnancy-specific formulations exist with appropriate purity standards).

Should I worry about heavy metals in fish oil?

Reputable supplements are molecularly distilled to remove heavy metals and PCBs and third-party tested for oxidation. Look for IFOS certification or equivalent. Algae oil avoids the marine contamination concern entirely.

The bottom line

Omega-3 has one of the most robust evidence bases in women's nutritional health: authorised EU health claims for heart, brain, and vision, plus meta-analysed data showing meaningful effects on dysmenorrhea and PMS over a 1 to 6 month timeline. Most European women fall well below the 250 mg/day EFSA target. Closing that gap, through fish, fish oil, or algae oil, is one of the higher-leverage moves in cycle-aware nutrition.

It is not part of the nōuxx routine, and that is honest. It is a complementary addition that earns its place on the evidence.

References

[1] Hakim M, Rahman N. Pain-free periods: Omega-3 insights. Nutrition & Dietetics : the Journal of the Dietitians Association of Australia 2024;81(3):347-348. doi.org/10.1111/1747-0080.12883

[2] Calder PC. Omega-3 fatty acids and inflammatory processes. Nutrients 2010;2(3):355-374. doi.org/10.3390/nu2030355

[3] EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA) and brain, eye and nerve development, maintenance of normal brain function, normal vision, normal cardiac function, and maternal health. EFSA Journal 2010;8(10):1796. doi.org/10.2903/j.efsa.2010.1796

[4] Hearty ÁP, et al. The intake of omega-3 oils and vegetable oils in the European Union. Food Additives &Amp; Contaminants: Part a 2025;42(12):1625-1638. doi.org/10.1080/19440049.2025.2575458

[5] Dietary Intake, Biological Status, and Barriers towards Omega-3 Intake in Elite Level (Tier 4), Female Athletes: Pilot Study. Nutrients 2023. mdpi.com/2072-6643/15/13/2821

[6] Calder PC. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?. British Journal of Clinical Pharmacology 2013;75(3):645-62. doi.org/10.1111/j.1365-2125.2012.04374.x

[7] Calder PC. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochemical Society Transactions 2017;45(5):1105-1115. doi.org/10.1042/bst20160474

[8] Snipe RMJ, et al. Omega‐3 long chain polyunsaturated fatty acids as a potential treatment for reducing dysmenorrhoea pain: Systematic literature review and meta‐analysis. Nutrition &Amp; Dietetics 2023;81(1):94-106. doi.org/10.1111/1747-0080.12835

[9] Mohammadi MM, et al. Effect of omega-3 fatty acids on premenstrual syndrome: A systematic review and meta-analysis. The Journal of Obstetrics and Gynaecology Research 2022;48(6):1293-1305. doi.org/10.1111/jog.15217

[10] Behboudi-Gandevani S, Hariri FZ, Moghaddam-Banaem L. The effect of omega 3 fatty acid supplementation on premenstrual syndrome and health-related quality of life: a randomized clinical trial. Journal of Psychosomatic Obstetrics and Gynaecology 2018;39(4):266-272. doi.org/10.1080/0167482X.2017.1348496

[11] Sohrabi N, et al. Evaluation of the effect of omega-3 fatty acids in the treatment of premenstrual syndrome: "a pilot trial". Complementary Therapies in Medicine 2013;21(3):141-6. doi.org/10.1016/j.ctim.2012.12.008

[12] Bailey E, et al. Comparative Bioavailability of DHA and EPA from Microalgal and Fish Oil in Adults. International Journal of Molecular Sciences 2025;26(19). doi.org/10.3390/ijms26199343

[13] Scientific Opinion on the Tolerable Upper Intake Level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA). EFSA Journal 2012;10(7). doi.org/10.2903/j.efsa.2012.2815

[14] Kumari R, et al. Effect of Exercise and Omega-3 Supplements on the Quality of Life of Young Female Patients With Primary Dysmenorrhea: A Randomized Controlled Trial. Cureus 2025;17(7):e88044. doi.org/10.7759/cureus.88044

[15] Xie L, et al. Effects of omega-3 fatty acids on chronic pain: a systematic review and meta-analysis. Frontiers in Medicine 2025;12. doi.org/10.3389/fmed.2025.1654661

[16] Robinson J, et al. Effect of nutritional interventions on the psychological symptoms of premenstrual syndrome in women of reproductive age: a systematic review of randomized controlled trials. Nutrition Reviews 2024;83(2):280-306. doi.org/10.1093/nutrit/nuae043

[17] Venugopalan VK, et al. Encapsulation and Protection of Omega-3-Rich Fish Oils Using Food-Grade Delivery Systems. Foods (Basel, Switzerland) 2021;10(7). doi.org/10.3390/foods10071566

[18] Microencapsulation of fish oil by spray drying: Impact on oxidative stability (Drusch et al., review). Trends in Food Science & Technology / J Food Eng — primary microencapsulation literature, summarised in the 2021 Foods review above.

[19] Perez-Palacios T, et al. Recent Developments in the Microencapsulation of Fish Oil and Natural Extracts: Procedure, Quality Evaluation and Food Enrichment. Foods (Basel, Switzerland) 2022;11(20). doi.org/10.3390/foods11203291

[20] Jackowski SA, et al. Oxidation levels of North American over-the-counter n-3 (omega-3) supplements and the influence of supplement formulation and delivery form on evaluating oxidative safety. Journal of Nutritional Science 2015;4:e30. doi.org/10.1017/jns.2015.21